DE60319021D1 - Method of treating sepsis - Google Patents

Method of treating sepsis

Info

Publication number
DE60319021D1
DE60319021D1 DE60319021T DE60319021T DE60319021D1 DE 60319021 D1 DE60319021 D1 DE 60319021D1 DE 60319021 T DE60319021 T DE 60319021T DE 60319021 T DE60319021 T DE 60319021T DE 60319021 D1 DE60319021 D1 DE 60319021D1
Authority
DE
Germany
Prior art keywords
alkyl
similar
treating sepsis
bond
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60319021T
Other languages
German (de)
Other versions
DE60319021T2 (en
Inventor
Che-Ming Teng
Shiow-Lin Pan
Jih-Hwa Guh
Sheng-Chu Kuo
Fang-Yuan Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yung Shin Pharm Industries Co Ltd
Original Assignee
Yung Shin Pharm Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yung Shin Pharm Industries Co Ltd filed Critical Yung Shin Pharm Industries Co Ltd
Application granted granted Critical
Publication of DE60319021D1 publication Critical patent/DE60319021D1/en
Publication of DE60319021T2 publication Critical patent/DE60319021T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

The present invention features a method for treating sepsis. The method includes administrating to a subject in need thereof an effective amount of a fused pyrazolyl compound of formula (I): <CHEM> in which n is 0, 1, 2, or 3; each of Ar1, Ar2, and Ar3, independently, is phenyl, pyridinyl, thienyl, furyl, or pyrrolyl; and each of R1, R2, R3, R4, R5, and R6, independently, is XYZ; or R1 and R2 together, R3 and R4 together, or R5 and R6 together are O(CH2)1-6O; in which X is a bond or C1 SIMILAR C6 alkyl, Y is a bond, O, S, OC(O), OC(O)(CH2)1-6C(O)O, C(O)O, C(O)S, C(O)NH, C(O)NC1 SIMILAR C6 alkyl, NH, or NC1 SIMILAR C6 alkyl, and Z is H, halogen, CN, NO2, or C1 SIMILAR C6 alkyl; and provided that one of R3 and R4 is not H.
DE60319021T 2002-01-25 2003-01-23 Method of treating sepsis Expired - Fee Related DE60319021T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35178802P 2002-01-25 2002-01-25
US351788P 2002-01-25

Publications (2)

Publication Number Publication Date
DE60319021D1 true DE60319021D1 (en) 2008-03-27
DE60319021T2 DE60319021T2 (en) 2009-02-05

Family

ID=23382397

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319021T Expired - Fee Related DE60319021T2 (en) 2002-01-25 2003-01-23 Method of treating sepsis

Country Status (7)

Country Link
US (2) US6943186B2 (en)
EP (1) EP1331223B1 (en)
JP (1) JP2003238405A (en)
KR (1) KR20030095197A (en)
AT (1) ATE386025T1 (en)
DE (1) DE60319021T2 (en)
TW (1) TWI264304B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209252A1 (en) * 2002-03-29 2005-09-22 Che-Ming Teng Cancer treatment
US7166293B2 (en) * 2002-03-29 2007-01-23 Carlsbad Technology, Inc. Angiogenesis inhibitors
US20050119278A1 (en) * 2002-05-16 2005-06-02 Che-Ming Teng Anti-angiogenesis methods
TW200539874A (en) * 2004-03-15 2005-12-16 Yung Shin Pharmaceutical Ind Preferential inhibition of release of pro-inflammatory cytokines
US7378532B2 (en) * 2004-03-26 2008-05-27 Yung Shin Pharmaceutical Ind. Co., Ltd. Fused pyrazolyl compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2701281B2 (en) * 1988-01-22 1998-01-21 吉富製薬株式会社 Pyrazolopyridine compound
JP2928079B2 (en) * 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1- (Substituted benzyl) -3- (substituted aryl) condensed pyrazoles, their production and use
NZ335092A (en) 1996-10-14 2002-02-01 Bayer Ag Heterocyclylmethyl-substituted or benzyl-substituted pyrazole derivatives, pharmaceuticals thereof and their use as inhibitors of the breakdown of cyclic guanosine monophosphate (cGMP)
DE19642255A1 (en) 1996-10-14 1998-04-16 Bayer Ag Use of 1-benzyl-3- (substituted-hetaryl) fused pyrazole derivatives
DE19744027A1 (en) * 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh New pyrazolo(3,4-b)pyridine derivatives useful as cGMP agonists
DE19744026A1 (en) * 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazole derivatives, their preparation and their use in medicinal products
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
GB0002666D0 (en) * 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels

Also Published As

Publication number Publication date
TW200302091A (en) 2003-08-01
US20030181502A1 (en) 2003-09-25
US20050187257A1 (en) 2005-08-25
KR20030095197A (en) 2003-12-18
US6943186B2 (en) 2005-09-13
EP1331223A1 (en) 2003-07-30
DE60319021T2 (en) 2009-02-05
JP2003238405A (en) 2003-08-27
TWI264304B (en) 2006-10-21
ATE386025T1 (en) 2008-03-15
EP1331223B1 (en) 2008-02-13

Similar Documents

Publication Publication Date Title
EA200101133A1 (en) A method for inhibiting the aggregation of amyloid proteins and visualizing amyloid deposits using isindoline derivatives
EA200100411A1 (en) SUBSTITUTED 3-CYANOHINOLINES AS PROTEINTHYROSINKINASE INHIBITORS
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
DE69328975D1 (en) AMINOMETHYLENE SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS ALSO SUBSTANCE P ANTAGONISTS
EA200100203A1 (en) DERIVATIVES 4,4-BIARILPIPERIDIN WITH ACTIVITY WITH RESPECT TO OPIOID RECEPTORS
DE60024830D1 (en) METHOD FOR PRODUCING HETEROARYL SUBSTITUTED UREA BONDING
CY1111951T1 (en) PAINYL-CARBOXAMID COMPOUNDS USEFUL FOR PANTS
EA200400006A1 (en) Benzoylsulfonamides and sulfonylbenzamidines for use as anti-tumor agents
ATE481987T1 (en) METHOD FOR RADIOFLUORIDATION OF BIOLOGICALLY ACTIVE VECTORS
ATE230392T1 (en) AMIDINOPHENYL-PYRROLIDINES, -PYRROLINES AND - ISOXAZOLIDINES AND THEIR DERIVATIVES
FR2810979B1 (en) NOVEL DIPHENYLUREA DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BG98740A (en) Substituted pyrazolylpyrazoles, methods for their preparation, preparation of intermediate products and the usage of the compounds as herbicides
WO2001009090A3 (en) Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
EA200100516A1 (en) DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE
DE69924292D1 (en) PYRAZOL COMPOUNDS AND ITS USE
DE60104825D1 (en) METHOD FOR PRODUCING 6-SUBSTITUTED (S) -NICOTINE DERIVATIVES AND INTERMEDIATE COMPOUNDS
EA200600860A1 (en) DERIVATIVES N-THIAZOL-2-ILBENZAMIDE
DE60319021D1 (en) Method of treating sepsis
TR200200125T2 (en) New aminothiazole derivatives, their preparation and pharmaceutical compositions containing them.
DE602004006379D1 (en) BENZTHIAZOLE-3 OXIDE FOR THE TREATMENT OF PROLIFERATIVE DISORDER
EA200100825A1 (en) NEW 1-ARYL-4-TIOTRIASINS
PT1446393E (en) 2-AMINO-THIAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NO INDUCTION
HUP9700955A2 (en) Substituted 2-naphtoylguanidine derivatives, their production, and pharmaceutical compositions containing them
DK1377574T3 (en) 6-phenylbenzonaphthyridines
DE60216610D1 (en) Use of fused pyrazole compounds for the manufacture of a medicament for the treatment of hypertension

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee